首页> 外文期刊>Nature clinical practice. Rheumatology >Hormone replacement therapy in systemic lupus erythematosus
【24h】

Hormone replacement therapy in systemic lupus erythematosus

机译:系统性红斑狼疮的激素替代疗法

获取原文
获取原文并翻译 | 示例
           

摘要

Systemic lupus erythematosus (SLE) mainly affects women of reproductive age. The infre-quency of first onset of the disease before puberty and after menopause, as well as exacerbation of the disease during periods of rapid hormonal changes (such as pregnancy, lactation and ovulation induction) -suggests that estrogen, an immunostimulatory hormone, might increase disease activity in patients with SLE.
机译:系统性红斑狼疮(SLE)主要影响育龄妇女。疾病在青春期之前和绝经后的首次发病率不高,以及在荷尔蒙快速变化时期(例如怀孕,泌乳和排卵诱导)疾病的恶化-建议雌激素(一种免疫刺激激素)可能会增加SLE患者的疾病活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号